| Bioactivity | GSK926 (compound 3) is a selective histone lysine methyltransferase EZH2 inhibitor (IC50=0.02 μM; Ki=7.9 nM), with SAM-competitive and cell-active properties. GSK926 can be used in cancer research[1]. |
| CAS | 1346704-13-9 |
| Formula | C29H35N7O2 |
| Molar Mass | 513.63 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Verma S K, et al. Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2[J]. ACS medicinal chemistry letters, 2012, 3(12): 1091-1096. |
GSK926
CAS: 1346704-13-9 F: C29H35N7O2 W: 513.63
GSK926 (compound 3) is a selective histone lysine methyltransferase EZH2 inhibitor (IC50=0.02 μM; Ki=7.9 nM), with SAM-
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.